Cardiovascular outcomes in long COVID-19: a systematic review and meta-analysis
Longitudinal Characterization Of Myocardial Injury In Acute On Chronic Heart Failure In Post-acute Covid-19 Readmissions: A Retrospective Analytic Cohort Study
“SARS-CoV-2 (CoV-2) myocardial injury in patients with acute on chronic heart failure (CHF) at index hospitalization has been well-characterized. Though post-acute COVID-19 (PAC) hospitalization(s) is less investigated despite evidence that CoV-2 induced inflammatory response persists for up to 3 months after initial infection.”
SARS-CoV-2 (CoV-2) myocardial injury in patients with acute on chronic heart failure (CHF) at index hospitalization has been well-characterized. Though post-acute COVID-19 (PAC) hospitalization(s) is less investigated despite evidence that CoV-2 induced inflammatory response persists for up to 3 months after initial infection.
COVID-19 and the heart: Acute and long-term treatment options
“Management of acute and long-term COVID-19 cardiovascular syndrome is challenging and should involve a multidisciplinary team including cardiologists, intensive care specialists, infectious disease specialists, and cardiothoracic surgery specialists. A number of promising therapies were investigated during the pandemic. This chapter aims to review the best available data on acute and long-term treatment options of COVID-19 cardiovascular syndrome.”
Management of acute and long-term COVID-19 cardiovascular syndrome is challenging and should involve a multidisciplinary team including cardiologists, intensive care specialists, infectious disease specialists, and cardiothoracic surgery specialists. A number of promising therapies were investigated during the pandemic. This chapter aims to review the best available data on acute and long-term treatment options of COVID-19 cardiovascular syndrome.
Cardiovascular Implications of Long COVID, Severe COVID
SARS-CoV-2 damages cardiomyocyte mitochondria and implicates long COVID-associated cardiovascular manifestations
Long COVID May Cause Long-Term Changes in the Heart and Lungs and May Lead to Cardiac and Pulmonary Diseases
“Mount Sinai study suggests COVID-19 infection should be considered a risk factor for future cardiopulmonary conditions”
History of COVID-19 doubles long-term risk of heart attack, stroke or death
928 - In Vitro Modeling of the Effects of Impaired HDL on Atherogenesis in Long COVID Syndrome
Study finds that HDL from Long COVID patients promotes key steps in early atherosclerosis.
Monocytes migrate more and take up more lipids, suggesting dysfunctional HDL may contribute to heart disease risk in Long COVID.
Doctors Warn COVID-19 Could Be a Hidden Trigger for Heart Attacks Long After Recovery
“A new study reveals that COVID-19 fuels dangerous plaque buildup in the arteries, making heart attacks and strokes more likely. Even after recovery, the risk remains high, stressing the importance of ongoing heart health monitoring.”
A new study reveals that COVID-19 fuels dangerous plaque buildup in the arteries, making heart attacks and strokes more likely. Even after recovery, the risk remains high, stressing the importance of ongoing heart health monitoring.
Covid may increase the risk of heart attacks, strokes, and deaths for three years after an infection, a new study suggests | CNN
“Covid-19 may increase the risk of heart attacks, strokes and deaths for three years after an infection, study suggests”
Covid-19 may increase the risk of heart attacks, strokes and deaths for three years after an infection, study suggests